Methotrexate and Malignancy in Rheumatoid Arthritis: Evidence, Risks, and Clinical Considerations.

Iwata S, Tada M, Koike R, Yamanishi Y, Fusama M, Tsuchiya H, Yamaoka K, Kameda H

DOI: 10.1093/mr/roag080
Published: 2026 Sep 1
Container: Modern rheumatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/mr/roag080,
  title = {Methotrexate and Malignancy in Rheumatoid Arthritis: Evidence, Risks, and Clinical Considerations.},
  author = {Iwata S and Tada M and Koike R and Yamanishi Y and Fusama M and Tsuchiya H and Yamaoka K and Kameda H},
  year = {2026},
  journal = {Modern rheumatology},
  doi = {10.1093/mr/roag080},
  url = {https://doi.org/10.1093/mr/roag080}
}

RIS

TY  - JOUR
TI  - Methotrexate and Malignancy in Rheumatoid Arthritis: Evidence, Risks, and Clinical Considerations.
AU  - Iwata S
AU  - Tada M
AU  - Koike R
AU  - Yamanishi Y
AU  - Fusama M
AU  - Tsuchiya H
AU  - Yamaoka K
AU  - Kameda H
PY  - 2026
JO  - Modern rheumatology
DO  - 10.1093/mr/roag080
UR  - https://doi.org/10.1093/mr/roag080
ER  -

APA

S, I., M, T., R, K., Y, Y., M, F., H, T., K, Y., & H, K. (2026). Methotrexate and Malignancy in Rheumatoid Arthritis: Evidence, Risks, and Clinical Considerations.. Modern rheumatology. https://doi.org/10.1093/mr/roag080

Source records

pubmed · retrieved 2026-09-26T03:07:49.387Z